SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
KaloBios Pharmaceuticals, Inc.' KB001 Antibody Shows Encouraging Safety and Activity in New Approach to Fighting Pseudomonas Infection in Cystic Fibrosis Patients